Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat

Neuroscience

Volumn 225, Issue , 2012, Pages 65-75

  Cao, T ^a,b   Thomas, T C ^b,d   Ziebell, J M ^b,d   Pauly, J R ^b,c   Lifshitz, J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Kentucky   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Alternate activation; Anti inflammatory; Classical activation; Neuroplasticity

Indexed keywords

IBUPROFEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE MARKER; ENZYME INACTIVATION; GENE EXPRESSION; GENETIC ASSOCIATION; MALE; MICROGLIA; MORBIDITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOLOGY; PERIKARYON; PRIMARY SOMATOSENSORY CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; THALAMUS VENTRAL NUCLEUS; TRAUMATIC BRAIN INJURY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN INJURIES; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IBUPROFEN; ISOQUINOLINES; MALE; MICROFILAMENT PROTEINS; MICROGLIA; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SOMATOSENSORY CORTEX; TIME FACTORS; TRITIUM; VENTRAL THALAMIC NUCLEI;

EID: 84866881618     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.08.058     Document Type: Article

References (72)

1. Benowitz L.I., Yin Y. Combinatorial treatments for promoting axon regeneration in the CNS: strategies for overcoming inhibitory signals and activating neurons' intrinsic growth state. Dev Neurobiol 2007, 67:1148-1165.
2. Boekhoff T.M., Ensinger E.M., Carlson R., Bock P., Baumgartner W., Rohn K., Tipold A., Stein V.M. Microglial contribution to secondary injury evaluated in a large animal model of human spinal cord trauma. J Neurotrauma 2011, 29:1000-1011.
3. Browne K.D., Iwata A., Putt M.E., Smith D.H. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp Neurol 2006, 201:301-307.
4. Bye N., Habgood M.D., Callaway J.K., Malakooti N., Potter A., Kossmann T., Morganti-Kossmann M.C. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol 2007, 204:220-233.
5. Chen M.K., Guilarte T.R. Translocator protein 18kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 2008, 118:1-17.
6. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418.
7. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflamm 2006, 3:27.
8. Colton C.A., Wilcock D.M. Assessing activation states in microglia. CNS Neurol Disord Drug Targets 2010, 9:174-191.
9. Cook N.L., Vink R., Donkin J.J., van den Heuvel C. Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. J Neurosci Res 2009, 87:34-41.
10. Cullheim S., Thams S. The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res Rev 2007, 55:89-96.
11. del Zoppo G.J., Milner R., Mabuchi T., Hung S., Wang X., Berg G.I., Koziol J.A. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38:646-651.
12. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008, 209:378-388.
13. Farfara D., Lifshitz V., Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J Cell Mol Med 2008, 12:762-780.
14. Farkas O., Povlishock J.T. Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res 2007, 161:43-59.
15. Fu Q., Hue J., Li S. Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition. J Neurosci 2007, 27:4154-4164.
16. Gao J.J., Diesl V., Wittmann T., Morrison D.C., Ryan J.L., Vogel S.N., Follettie M.T. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J Leukoc Biol 2002, 72:1234-1245.
17. Ghajar J., Ivry R.B. The predictive brain state: timing deficiency in traumatic brain injury?. Neurorehabil Neural Repair 2008, 22:217-227.
18. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
19. Graeber M.B. Changing face of microglia. Science 2010, 330:783-788.
20. Graham D.I., Adams J.H., Nicoll J.A., Maxwell W.L., Gennarelli T.A. The nature, distribution and causes of traumatic brain injury. Brain Pathol 1995, 5:397-406.
21. Graham D.I., Gennarelli T.A., McIntosh T.K. Trauma. Greenfield's neuropathology 2002, Vol. 7th:823-898. Arnold Publishers, London.
22. Griesbach G.S., Hovda D.A., Molteni R., Gomez-Pinilla F. Alterations in BDNF and synapsin I within the occipital cortex and hippocampus after mild traumatic brain injury in the developing rat: reflections of injury-induced neuroplasticity. J Neurotrauma 2002, 19:803-814.
23. Grossman R., Shohami E., Alexandrovich A., Yatsiv I., Kloog Y., Biegon A. Increase in peripheral benzodiazepine receptors and loss of glutamate NMDA receptors in a mouse model of closed head injury: a quantitative autoradiographic study. Neuroimage 2003, 20:1971-1981.
24. Hall K.D., Lifshitz J. Diffuse traumatic brain injury initially attenuates and later expands activation of the rat somatosensory whisker circuit concomitant with neuroplastic responses. Brain Res 2010, 1323:161-173.
25. Harris J.L., Reeves T.M., Phillips L.L. Injury modality, survival interval, and sample region are critical determinants of qRT-PCR reference gene selection during long-term recovery from brain trauma. J Neurotrauma 2009, 26:1669-1681.
26. Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol 2009, 4:389-398.
27. Hinzman J., Thomas T.C., Quintero J., Gerhardt G., Lifshitz J. Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury. J Neurotrauma 2012, 29:1197-1208.
28. Horn K.P., Busch S.A., Hawthorne A.L., van Rooijen N., Silver J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci 2008, 28:9330-9341.
29. Hosseini A.H., Lifshitz J. Brain injury forces of moderate magnitude elicit the fencing response. Med Sci Sports Exerc 2009, 41:1687-1697.
30. Hutson C.B., Lazo C.R., Mortazavi F., Giza C.C., Hovda D., Chesselet M.F. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. J Neurotrauma 2011, 28:1783-1801.
31. Kelley B.J., Farkas O., Lifshitz J., Povlishock J.T. Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and Wallerian degeneration. Exp Neurol 2006, 198:350-360.
32. Kelley B.J., Lifshitz J., Povlishock J.T. Neuroinflammatory responses after experimental diffuse traumatic brain injury. J Neuropathol Exp Neurol 2007, 66:989-1001.
33. Kelso M.L., Scheff S.W., Pauly J.R., Loftin C.D. Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice. BMC Neurosci 2009, 10:108.
34. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444.
35. Lai A.Y., Todd K.G. Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 2008, 56:259-270.
36. Learoyd A.E., Lifshitz J. Comparison of rat sensory behavioral tasks to detect somatosensory morbidity after diffuse brain-injury. Behav Brain Res 2012, 226:197-204.
37. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 2001, 24:169-181.
38. Lifshitz J. Fluid percussion injury. Animal models of acute neurological injuries 2008, The Humana Press, Inc., Totowa, NJ. Z.C.X. Jun Chen, X. Xiao-Ming, H.Z. Jhon (Eds.).
39. Lifshitz J., Kelley B.J., Povlishock J.T. Perisomatic thalamic axotomy after diffuse traumatic brain injury is associated with atrophy rather than cell death. J Neuropathol Exp Neurol 2007, 66:218-229.
40. Lifshitz J., Lisembee A.M. Neurodegeneration in the somatosensory cortex after experimental diffuse brain injury. Brain Struct Funct 2012, 217:49-61.
41. Ling Z., Zhu Y., Tong C., Snyder J.A., Lipton J.W., Carvey P.M. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol 2006, 199:499-512.
42. Little K.Y., McLaughlin D.P., Zhang L., McFinton P.R., Dalack G.W., Cook E.H., Cassin B.J., Watson S.J. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. Arch Gen Psychiatry 1998, 55:793-799.
43. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
44. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
45. McAllister T.W. Neuropsychiatric sequelae of head injuries. Psychiatr Clin North Am 1992, 15:395-413.
46. McNamara K.C., Lisembee A.M., Lifshitz J. The whisker nuisance task identifies a late-onset, persistent sensory sensitivity in diffuse brain-injured rats. J Neurotrauma 2010, 27:695-706.
47. Millis S.R., Rosenthal M., Novack T.A., Sherer M., Nick T.G., Kreutzer J.S., High W.M., Ricker J.H. Long-term neuropsychological outcome after traumatic brain injury. J Head Trauma Rehabil 2001, 16:343-355.
48. Morganti-Kossmann M.C., Rancan M., Stahel P.F., Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002, 8:101-105.
49. Morganti-Kossmann M.C., Satgunaseelan L., Bye N., Kossmann T. Modulation of immune response by head injury. Injury 2007, 38:1392-1400.
50. Neumann H., Kotter M.R., Franklin R.J. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295.
51. Park E.M., Cho B.P., Volpe B.T., Cruz M.O., Joh T.H., Cho S. Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression. Neuroscience 2005, 132:625-631.
52. Patel P.M., Drummond J.C., Sano T., Cole D.J., Kalkman C.J., Yaksh T.L. Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats. Brain Res 1993, 614:315-324.
53. Perry V.H., Nicoll J.A., Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6:193-201.
54. Perry V.H., O'Connor V. The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective. ASN Neuro 2010, 2:e00047.
55. Popovich P.G., Longbrake E.E. Can the immune system be harnessed to repair the CNS?. Nat Rev Neurosci 2008, 9:481-493.
56. Povlishock J.T., Katz D.I. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil 2005, 20:76-94.
57. Prinz M., Priller J., Sisodia S.S., Ransohoff R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 2011, 14:1227-1235.
58. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.
59. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998, 4:814-821.
60. Rojo D.R., Prough D.S., Falduto M.T., Boone D.R., Micci M.A., Kahrig K.M., Crookshanks J.M., Jimenez A., Uchida T., Cowart J.C., Hawkins B.E., Avila M., DeWitt D.S., Hellmich H.L. Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury. PLoS One 2011, 6:e23111.
61. Ross S.M. Peirce's criterion for the elimination of suspect experimental data. J Eng Technol 2003, 20:38-41.
62. Semple B.D., Bye N., Rancan M., Ziebell J.M., Morganti-Kossmann M.C. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab 2010, 30:769-782.
63. Semple B.D., Bye N., Ziebell J.M., Morganti-Kossmann M.C. Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis 2010, 40:394-403.
64. Soares H.D., Hicks R.R., Smith D., McIntosh T.K. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 1995, 15:8223-8233.
65. Thomas T.C., Hinzman J.M., Gerhardt G.A., Lifshitz J. Hypersensitive glutamate signaling correlates with the development of late-onset behavioral morbidity in diffuse brain-injured circuitry. J Neurotrauma 2012, 29:187-200.
66. van Bregt D.R., Thomas T.C., Hinzman J.M., Cao T., Liu M., Bing G., Gerhardt G.A., Pauly J.R., Lifshitz J. Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat. Exp Neurol 2012, 234:8-19.
67. Venkatesan C., Chrzaszcz M., Choi N., Wainwright M.S. Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J Neuroinflamm 2010, 7:32.
68. Wang X., Budel S., Baughman K., Gould G., Song K.H., Strittmatter S.M. Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma 2009, 26:81-95.
69. Wei H.H., Lu X.C., Shear D.A., Waghray A., Yao C., Tortella F.C., Dave J.R. NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J Neuroinflamm 2009, 6:19.
70. Yeates G.N., Gracey F., McGrath J.C. A biopsychosocial deconstruction of " personality change" following acquired brain injury. Neuropsychol Rehabil 2008, 18:566-589.
71. Ziebell J.M., Bye N., Semple B.D., Kossmann T., Morganti-Kossmann M.C. Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury. Brain Res 2011, 1414:94-105.
72. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.